AxoGen Inc. (AXGN)
AxoGen Statistics
Share Statistics
AxoGen has 44.01M shares outstanding. The number of shares has increased by 1.86% in one year.
| Shares Outstanding | 44.01M |
| Shares Change (YoY) | 1.86% |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | 82.89% |
| Shares Floating | 41.88M |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.24M, so 2.83% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short % of Shares Out | 2.83% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 2.15 |
Valuation Ratios
The PE ratio is -73.2 and the forward PE ratio is 60.16. AxoGen's PEG ratio is 1.33.
| PE Ratio | -73.2 |
| Forward PE | 60.16 |
| PS Ratio | 3.89 |
| Forward PS | 2.2 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 1.33 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AxoGen Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0.4 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is null%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | null% |
| Revenue Per Employee | $415,383.59 |
| Profits Per Employee | $-22,093.13 |
| Employee Count | 451 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 87.09% in the last 52 weeks. The beta is 0.99, so AxoGen's price volatility has been higher than the market average.
| Beta | 0.99 |
| 52-Week Price Change | 87.09% |
| 50-Day Moving Average | 17.54 |
| 200-Day Moving Average | 12.71 |
| Relative Strength Index (RSI) | 64.23 |
| Average Volume (20 Days) | 448.03K |
Income Statement
In the last 12 months, AxoGen had revenue of 187.34M and earned -9.96M in profits. Earnings per share was -0.23.
| Revenue | 187.34M |
| Gross Profit | 141.98M |
| Operating Income | -3.29M |
| Net Income | -9.96M |
| EBITDA | -3.29M |
| EBIT | -3.29M |
| Earnings Per Share (EPS) | -0.23 |
Balance Sheet
The company has 0 in cash and 0 in debt, giving a net cash position of 0.
| Cash & Cash Equivalents | 0 |
| Total Debt | 0 |
| Net Cash | 0 |
| Retained Earnings | 0 |
| Total Assets | 191.99M |
| Working Capital | 63.22M |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 75.79%, with operating and profit margins of -1.75% and -5.32%.
| Gross Margin | 75.79% |
| Operating Margin | -1.75% |
| Pretax Margin | -5.32% |
| Profit Margin | -5.32% |
| EBITDA Margin | -1.75% |
| EBIT Margin | -1.75% |
| FCF Margin | n/a |
Dividends & Yields
AXGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1.15% |
| FCF Yield | 0% |
Analyst Forecast
The average price target for AXGN is $23, which is 15% higher than the current price. The consensus rating is "Buy".
| Price Target | $23 |
| Price Target Difference | 15% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 11, 1994. It was a backward split with a ratio of 20:21.
| Last Split Date | Jul 11, 1994 |
| Split Type | backward |
| Split Ratio | 20:21 |
Scores
| Altman Z-Score | 4.75 |
| Piotroski F-Score | 1 |